header_spotlight
header_spotlight

Patient Access to Medical Technology

The North-South NHS divide: how where you are – not what you need – dictates your care
– August 2017

The NHS has long strived to deliver equity of access to patients regardless of their location across the UK. NICE was originally established to help ensure that patients could access innovative treatments regardless of where they live in the country. Following this, the Government established the 18 week referral to treatment waiting target to ensure that patients get access in a timely manner.

The Medical Technology Group (MTG) examined data from all 209 Clinical Commissioning Groups (CCGs) from across England to find out how effective they are at giving patients access to medical technology.

Download the report.

report_button_light

NHS Initiatives on innovation

Déjà Review: What lessons can be learnt from the past?
– June 2016

Improving the way the NHS uses innovation has become the holy grail of NHS efficiency. In 2004, Derek Wanless described the NHS as a ‘late and slow adopter of innovation’ in his review, ‘Securing Good Health for the Whole Population’. Since that report many people would argue that the situation remains the same, despite a series of initiatives and reports promoting better use of innovation.

In this report The Medical Technology Group (MTG) considered what can be learnt from previous initiatives and suggested ways the Accelerated Access Review (AAR) can have most impact.

Download the report.

report_button_dark

Unplanned Admissions

Admissions of Failure – The truth about unplanned admissions in the NHS – November 2015

Unplanned (or emergency) hospital admissions account for more than a third – 5.4 million – of all hospital admissions and two thirds of all hospital bed days. This is bad for the patients admitted in an emergency – disproportionately frail, elderly and poor. It is bad for other patients, disrupting their care and delaying appointments. It is extremely costly to the NHS – the cost was 11 billion GBP in 2010/11 alone.

Tackling unplanned admissions is vital to ensuring the Five Year Forward View is successfully implemented.

Download the report.

report_button_light

Innovation, Health, Wealth

Innovation, Health, Wealth – a Scorecard – June 2015

Three and a half years after the launch of the NHS Innovation, Health and Wealth (IHW) scheme in December 2011, the Medical Technology Group (MTG) published a report detailing the progress made by IHW on the six high impact innovations which were to be spread through the NHS at ‘pace and scale’.

The data collected in the report indicates that the push for greater adoption of innovations has largely failed to produce significant results. While some successes have been noted from IHW; such as the launch of Academic Health Science Networks, there has been a widespread lack of uptake on the high impact innovations.

Download the report.

report_button_dark

Infection Control

Infection Prevention and Control – Combatting a problem that has not gone away – September 2014

Following a Freedom of Information request to all NHS Acute Trusts in England, in September 2014 the MTG published a report: Infection Prevention and Control – Combatting a problem that has not gone away that revealed that the majority of Trusts were unaware of the full scale or the operational and financial impact of five common infections: sepsis; catheter-associated urinary tract infections; catheter-related blood infections; ventilator-associated pneumonia; and norovirus. The MTG called on the Government to develop a strategy for using technology for infection prevention and control.

Download the report.

report_button_light

Hip and Knee Surgery

Hip and Knee Surgery: Combating Patient Lotteries
– November 2013

In November 2013, the MTG published a report into waiting times for knee and hip replacements on the National Health Service. The report reviewed ten years of government data on knee and hip replacement, and data from Freedom of Information requests to acute NHS hospital trusts in England. The report suggested that patient experiences vary significantly according to the financial calendar and where they live.

Download the report.

report_button_dark

Uterine Artery / Fibroid Embolisation

A review of the provision of and access to Uterine Artery / Fibroid Embolisation, a treatment for Fibroids for women in England – December 2011

In 2011 the MTG and patient support group FEmISA published a report: ‘The provision of and access to Uterine Artery / Fibroid Embolisation, a less invasive treatment for fibroids for women’. The report, which was welcomed by the British Society of Interventional Radiologists, highlighted a lack of coherent commissioning in England, despite National Institute for Health and Care Excellence clinical guidelines recommending UFE as a first line treatment for symptomatic fibroids.

A review of the provision of and access to Uterine Artery / Fibroid Embolisation, a treatment for Fibroids for women in England.

Download the report.

report_button_light

Insulin Pump Provision

Pump Action: A Review of Insulin Pump Uptake and
NICE Guidance in English Primary Care Trusts (PCTs)
– December 2010

In 2010 the MTG made a Freedom of Information request to Primary Care Trusts in England on the provision of insulin pumps to patients with Type 1 diabetes. It found the average to be 3.9 per cent compared to the 12 per cent benchmark recommended by the National Institute for Health and Clinical Excellence. The findings were the subject of an Early Day Motion tabled by Adrian Sanders MP on December 9, 2010.

Download the report.

report_button_dark

Medical Technology Economics

Making the Economic Case for Medical Technology – 2004

In 2004, the MTG’s report ‘Making the Economic Case for Medical Technology’ suggested that increasing the provision of medical technology can “help patients better manage their conditions” and lead a “longer and relatively healthy life”. It also suggested that by making greater use of technology there are cost benefits for the National Health Service. The report was the subject of an Early Day Motion tabled by Ian Gibson MP. The motion was signed by 30 Members of Parliament.

Quick Links